drugset / Trial / NCT03801226

Zero Sodium Peritoneal Dialysate Protocol Pilot Study

NCT03801226

Phase 0 Completed 12 enrolled Yale University
RandomizedCrossoverOpen-labelDiagnostic

Summary

The following pilot study will be undertaken to determine the effects of use of a zero-sodium peritoneal dialysate solution (10% dextrose in sterile water) on sodium removal as compared to a standard peritoneal dialysis solution.

Timeline

Start
2018-12-01
Primary completion
2019-05-01
Completion
2019-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextrose Unknown 10 % Other
Subject Dianeal Low-Calcium Unknown 4.25 % Other